{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:51:34Z","timestamp":1794873094725,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.expneurol.2024.114849","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:52:45Z","timestamp":1718128365000},"page":"114849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model"],"prefix":"10.1016","volume":"379","author":[{"given":"Wenjuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.114849_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2024.114849_bb0010","doi-asserted-by":"crossref","first-page":"3041969","DOI":"10.1155\/2021\/3041969","article-title":"Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer","volume":"2021","author":"Allahou","year":"2021","journal-title":"Int. J. Biomater."},{"key":"10.1016\/j.expneurol.2024.114849_bb0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.STR.27.9.1616","article-title":"Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model","volume":"27","author":"Belayev","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.114849_bb0020","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.expneurol.2024.114849_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113494","article-title":"Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: a translational perspective","volume":"335","author":"Candelario-Jalil","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114849_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biomaterials.2016.05.018","article-title":"Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles","volume":"100","author":"England","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.expneurol.2024.114849_bb0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/bc.bc_52_22","article-title":"Neuroprotective approach in acute ischemic stroke: a systematic review of clinical and experimental studies","volume":"8","author":"Eren","year":"2022","journal-title":"Brain Circ."},{"key":"10.1016\/j.expneurol.2024.114849_bb0040","first-page":"143","article-title":"Lipid peroxidation-dependent cell death regulated by GPx4 and Ferroptosis","volume":"403","author":"Imai","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.expneurol.2024.114849_bb0045","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","article-title":"Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.expneurol.2024.114849_bb0050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.expneurol.2024.114849_bb0055","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2024.114849_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12274-020-2930-6","article-title":"The enhanced protective effects of salvianic acid A: a functionalized nanoparticles against ischemic stroke through increasing the permeability of the blood-brain barrier","volume":"13","author":"Li","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.expneurol.2024.114849_bb0065","doi-asserted-by":"crossref","first-page":"1587922","DOI":"10.1155\/2021\/1587922","article-title":"Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury","volume":"2021","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2024.114849_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11658-020-00205-0","article-title":"Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis","volume":"25","author":"Liu","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.expneurol.2024.114849_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainresbull.2022.12.009","article-title":"Ferrostatin-1 alleviates cerebral ischemia\/reperfusion injury through activation of the AKT\/GSK3\u03b2 signaling pathway","volume":"193","author":"Liu","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2024.114849_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2016.11.033","article-title":"Antioxidants and HNE in redox homeostasis","volume":"111","author":"\u0141uczaj","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2024.114849_bb0085","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1161\/STROKEAHA.121.032241","article-title":"Cerebroprotection for acute ischemic stroke: looking ahead","volume":"52","author":"Lyden","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.114849_bb0090","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.121.034947","article-title":"Top priorities for cerebroprotective studies-a paradigm shift: report from STAIR XI","volume":"52","author":"Lyden","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.114849_bb0095","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.expneurol.2024.114849_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","article-title":"GPX4-independent ferroptosis-a new strategy in disease's therapy","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2024.114849_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.05.032","article-title":"Solid lipid nanoparticles for hydrophilic drugs","volume":"335","author":"Mirchandani","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.expneurol.2024.114849_bb0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O\u2019Collins","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2024.114849_bb0115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7150\/thno.64806","article-title":"Dodging blood brain barrier with \u201cnano\u201d warriors: novel strategy against ischemic stroke","volume":"12","author":"Parvez","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.expneurol.2024.114849_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174461","article-title":"Dauricine alleviated secondary brain injury after intracerebral hemorrhage by upregulating GPX4 expression and inhibiting ferroptosis of nerve cells","volume":"914","author":"Peng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114849_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2016.07.003","article-title":"Zinc contributes to acute cerebral ischemia-induced blood-brain barrier disruption","volume":"95","author":"Qi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.114849_bb0130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/cns.13875","article-title":"Normobaric hyperoxia plays a neuroprotective role after cerebral ischemia by maintaining the redox homeostasis and the level of connexin43 in astrocytes","volume":"28","author":"Qi","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2024.114849_bb0135","article-title":"Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: at a glance","volume":"153","author":"Rahman","year":"2022","journal-title":"Biomed. Pharmacother.= Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.expneurol.2024.114849_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13346-019-00696-1","article-title":"Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method","volume":"10","author":"Ranjan","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.expneurol.2024.114849_bb0145","article-title":"Delivery of DNA into human cells by functionalized lignin nanoparticles","volume":"15","author":"Riley","year":"2022","journal-title":"Materials (Basel, Switzerland)"},{"key":"10.1016\/j.expneurol.2024.114849_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2024.114849_bb0155","doi-asserted-by":"crossref","first-page":"5080843","DOI":"10.1155\/2019\/5080843","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and Ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2024.114849_bb0160","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.expneurol.2024.114849_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.expneurol.2024.114849_bb0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2024.114849_bb0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/IJN.S384675","article-title":"Anti-oxidative, anti-apoptotic, and M2 polarized DSPC liposome nanoparticles for selective treatment of atherosclerosis","volume":"18","author":"Wan","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.expneurol.2024.114849_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10276","article-title":"Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis","volume":"7","author":"Wang","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.expneurol.2024.114849_bb0185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/bc.bc_33_21","article-title":"Progress and challenges in preclinical stroke recovery research","volume":"7","author":"Wolf","year":"2021","journal-title":"Brain Circ."},{"key":"10.1016\/j.expneurol.2024.114849_bb0190","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.2147\/IJN.S344318","article-title":"Endogenous Oleoylethanolamide crystals loaded lipid nanoparticles with enhanced hydrophobic drug loading capacity for efficient stroke therapy","volume":"16","author":"Wu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.expneurol.2024.114849_bb0195","article-title":"The mechanism of ferroptosis regulating oxidative stress in ischemic stroke and the regulation mechanism of natural pharmacological active components","volume":"154","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother.= Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.expneurol.2024.114849_bb0200","first-page":"409","article-title":"Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia\/reperfusion rats","volume":"10","author":"Yao","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.expneurol.2024.114849_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106670","article-title":"Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation","volume":"103","author":"Ye","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2024.114849_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-0716-2954-3_4","article-title":"Thin-film hydration followed by extrusion method for liposome preparation","volume":"2622","author":"Zhang","year":"2023","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.expneurol.2024.114849_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.615372","article-title":"Ferroptosis and its multifaceted roles in cerebral stroke","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114849_bb0220","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.msec.2018.02.004","article-title":"Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine","volume":"92","author":"Zhao","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:17:56Z","timestamp":1722043076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"alternative-id":["S0014488624001754"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114849","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114849"}}